• Nearsightedness in Children--A Study to Determine if Daily Eye Drops Can Slow the Progression

    Official Title

    CHILDHOOD ATROPINE FOR MYOPIA PROGRESSION (CHAMP): A 3-ARM RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, PHASE 3 STUDY OF ATROPINE SULFATE OPHTHALMIC SOLUTION 0.01% AND 0.02%

    Purpose

    The purpose of the study is to determine if a daily eye drop will help slow the progression of nearsightedness in children.

    Could this study be right for you?

    Your child may be eligible for this study if he/she is:
    *Ages 3- 17
    *Nearsighted

    Participants will complete visits for follow-up (every 6 months) and to pick up study eye drops (every 3 months).

    Please have your child’s current eye glasses prescription available when you call.

    Age Range

    3 and up